Breast cancer and climacteric complaints: Weighing up risks of hormone therapy against quality of life

Henk R. Franke; Monique M.A. Brood-van Zanten; Curt W. Burger; Marius J. van der Mooren; Peter Kenemans

doi:10.1016/j.ejogrb.2007.05.002

Breast cancer and climacteric complaints: Weighing up risks of hormone therapy against quality of life

Henk R. Franke^*
, Monique M.A. Brood-van Zanten
, Curt W. Burger
, Marius J. van der Mooren
, Peter Kenemans

^*Corresponding author for this work

Medisch Spectrum Twente
VU Medical Center

Research output: Contribution to journal › Review article › Academic › peer-review

Abstract

Women with severe menopausal symptoms can, at their request, be treated effectively with hormone therapy. Good information about the advantages and disadvantages of hormone therapy should precede this decision. For women with breast cancer or an inherited increased risk of breast cancer and severe, often therapy-related climacteric symptoms, a high degree of reticence is appropriate in relation to hormone therapy. If the quality of life is seriously affected in these often-young women with these iatrogenic climacteric complaints, then careful consideration must be given to the various treatment modalities.

Original language	English
Pages (from-to)	143-146
Number of pages	4
Journal	European Journal of Obstetrics and Gynecology and Reproductive Biology
Volume	134
Issue number	2
DOIs	https://doi.org/10.1016/j.ejogrb.2007.05.002
Publication status	Published - Oct 2007

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Breast cancer
Climacteric complaints
Hormone therapy
Quality of life

Access to Document

10.1016/j.ejogrb.2007.05.002

Cite this

@article{a2af4aad357c4b56bab77d0a5490c944,

title = "Breast cancer and climacteric complaints: Weighing up risks of hormone therapy against quality of life",

abstract = "Women with severe menopausal symptoms can, at their request, be treated effectively with hormone therapy. Good information about the advantages and disadvantages of hormone therapy should precede this decision. For women with breast cancer or an inherited increased risk of breast cancer and severe, often therapy-related climacteric symptoms, a high degree of reticence is appropriate in relation to hormone therapy. If the quality of life is seriously affected in these often-young women with these iatrogenic climacteric complaints, then careful consideration must be given to the various treatment modalities.",

keywords = "Breast cancer, Climacteric complaints, Hormone therapy, Quality of life",

author = "Franke, \{Henk R.\} and \{Brood-van Zanten\}, \{Monique M.A.\} and Burger, \{Curt W.\} and \{van der Mooren\}, \{Marius J.\} and Peter Kenemans",

year = "2007",

month = oct,

doi = "10.1016/j.ejogrb.2007.05.002",

language = "English",

volume = "134",

pages = "143--146",

journal = "European Journal of Obstetrics and Gynecology and Reproductive Biology",

issn = "0301-2115",

publisher = "Elsevier Ireland Ltd",

number = "2",

}

Breast cancer and climacteric complaints: Weighing up risks of hormone therapy against quality of life. / Franke, Henk R.; Brood-van Zanten, Monique M.A.; Burger, Curt W. et al.
In: European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 134, No. 2, 10.2007, p. 143-146.

Research output: Contribution to journal › Review article › Academic › peer-review

TY - JOUR

T1 - Breast cancer and climacteric complaints

T2 - Weighing up risks of hormone therapy against quality of life

AU - Franke, Henk R.

AU - Brood-van Zanten, Monique M.A.

AU - Burger, Curt W.

AU - van der Mooren, Marius J.

AU - Kenemans, Peter

PY - 2007/10

Y1 - 2007/10

N2 - Women with severe menopausal symptoms can, at their request, be treated effectively with hormone therapy. Good information about the advantages and disadvantages of hormone therapy should precede this decision. For women with breast cancer or an inherited increased risk of breast cancer and severe, often therapy-related climacteric symptoms, a high degree of reticence is appropriate in relation to hormone therapy. If the quality of life is seriously affected in these often-young women with these iatrogenic climacteric complaints, then careful consideration must be given to the various treatment modalities.

AB - Women with severe menopausal symptoms can, at their request, be treated effectively with hormone therapy. Good information about the advantages and disadvantages of hormone therapy should precede this decision. For women with breast cancer or an inherited increased risk of breast cancer and severe, often therapy-related climacteric symptoms, a high degree of reticence is appropriate in relation to hormone therapy. If the quality of life is seriously affected in these often-young women with these iatrogenic climacteric complaints, then careful consideration must be given to the various treatment modalities.

KW - Breast cancer

KW - Climacteric complaints

KW - Hormone therapy

KW - Quality of life

UR - https://www.scopus.com/pages/publications/34548821903

U2 - 10.1016/j.ejogrb.2007.05.002

DO - 10.1016/j.ejogrb.2007.05.002

M3 - Review article

C2 - 17574325

SN - 0301-2115

VL - 134

SP - 143

EP - 146

JO - European Journal of Obstetrics and Gynecology and Reproductive Biology

JF - European Journal of Obstetrics and Gynecology and Reproductive Biology

IS - 2

ER -

Breast cancer and climacteric complaints: Weighing up risks of hormone therapy against quality of life

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this